If concomitant administration cannot be avoided, monitor patients more frequently for myelosuppression, renal, and gastrointestinal toxicity
Pubmed Abstract Google Scholar View reference in article 95
pmid:30764523 23
Administration Guidelines Inject subcutaneously into the abdomen, thigh, or upper arm Rotate injection sites weekly to avoid lipodystrophy May be administered with or without food Store as directed typically refrigerated at 28C Use only under the supervision of a licensed healthcare provider Cagrilintide in Combination Therapy: The CagriSema Approach One of the most clinically significant developments surrounding Cagrilintide 10mg is its evaluation in combination with semaglutide marketed as CagriSema
For individuals struggling with dehydration, IV hydration therapy can provide it immediately
Endocrinology 137(7):29682978 Mitchell PD, Salter BM, Oliveria JP, El-Gammal A, Tworek D, Smith SG et al (2017) Glucagon-like peptide-1 receptor expression on human eosinophils and its regulation of eosinophil activation
